Golden Heaven Group Holdings Ltd. engages in the construction, development, management, and operation of urban amusement parks, water parks, amusement projects, and amusement facilities in China. Its services include sales of in-park recreation, rental income, and Park service fees. The company was founded on January 8, 2020 and is headquartered in Nanping, China.

Brag House Holdings, Inc. engages in the provision of an electronic video game sports (eSports) platform. It is also involved in marketing and recruiting, networks, events and production, and partnerships and sponsorships among eSports casual college gamers and fans. The company was founded by Lavell Juan Malloy II and Daniel Leibovich on February 23, 2018 and is headquartered in Montclair, NJ.

Open Lending Corp. provides lending enablement and risk analytics to credit unions, regional banks and the captive finance companies of original equipment manufacturers (OEM Captives). It specializes in risk-based pricing and modeling and provides automated decision-technology for automotive lenders throughout the United States. The firm addresses the financing needs of near-prime and non-prime borrowers, or borrowers with a credit score who are underserved in the automotive finance industry. The company was founded by John J. Flynn, Sandy Watkins and Ross M. Jessup in 2000 and is headquartered in Austin, TX.

Silynxcom Ltd. engages in the development, manufacture, market and sells communication headset devices. It specializes in developing the In-Ear Headset device, a subsegment of the Personal Headset Device market. The In-Ear Headset device is used in both training and operations by the military, law enforcement, and disaster recovery industry professionals. The company was founded on August 22, 2021 and is headquartered in Netanya, Israel.

Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG-806 a non-covalent small molecule therapeutic agent. The company was founded on September 5, 1986 and is headquartered in Toronto, Canada.

GRI Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapies for inflammatory, fibrotic, and autoimmune diseases. It focuses on its lead program, GRI-0621, an inhibitor of type 1 invariant Natural Killer T (iNKT) cell activity and is being developed as a novel oral therapeutic for the treatment of idiopathic pulmonary fibrosis. The company was founded by Vipin Kumar Chaturvedi in May 2009 and is headquartered in La Jolla, CA.

Curis, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948, CA-170 and CA-327. The CUDC-907 pipeline is an orally available small molecule inhibitor of HDAC and PI3K enzymes. The CA-170 pipeline is an also an orally-available small molecule antagonist of PD-L1 and VISTA immune checkpoints. The company was founded on February 14, 2000 and is headquartered in Lexington, MA.

Universe Pharmaceuticals, Inc. is a pharmaceutical company. The firm is focused on the manufacturing, marketing, sales, and distribution of traditional Chinese medicine derivative products. It also sells biomedical drugs, medical instruments, traditional Chinese medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. The company was founded on March 2, 1998 and is headquartered in Ji'an, China.

Nuvve Holding Corp. engages in the provision of a commercial vehicle-to-grid (V2G) technology platform. Its V2G technology, Grid Integrated Vehicle (GIVeTM) platform, enables its users to link multiple electric vehicle (EV) batteries into a virtual power plant to provide bi-directional services to the electrical grid. The firm also enables electric vehicle (EV) batteries to store and resell unused energy back to the local electric grid and provide other grid services. The company was founded in 2010 and is headquartered in San Diego, CA.

Orchestra Biomed Holdings, Inc. engages in the provision of biomedical technologies to patients through risk-reward-sharing partnerships with medical device companies. The company was founded on May 25, 2020 and is headquartered in New Hope, PA.